Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • GlaxoSmithKline

    - PMLiVE

    Osivax initiates phase 2b trial of influenza A vaccine candidate

    The study aims to enrol 2,850 participants across 16 sites in Europe

    - PMLiVE

    Moderna shares positive phase 3 results for mRNA flu vaccine candidate

    More than 600,000 people in the US were hospitalised due to flu-related illness last year

    - PMLiVE

    BioNTech expands mRNA capabilities with $1.25bn CureVac acquisition

    The deal will support the advancement of BioNTech’s mRNA-based cancer immunotherapies

    - PMLiVE

    Sanofi receives FDA fast track designation for COVID-19/flu combination vaccines

    The combined vaccine approach could simplify immunisation practices and lead to higher uptake

    - PMLiVE

    Seven strategic steps to enhance patient recruitment & retention in your influenza studies

    The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be challenging for influenza studies, especially given the typically short patient...

    Innovative Trials

    - PMLiVE

    Novavax announces FDA clinical hold lift on phase 3 COVID-19/flu vaccine study

    The serious adverse event reported was found to be unrelated to the vaccine

    - PMLiVE

    Is your influenza clinical trial prepared for the upcoming flu season? Part 3

    This blog will discuss some important aspects to consider to maximise patient retention on your flu clinical trials. For more information on patient recruitment considerations, check out our previous blogs...

    Innovative Trials

    - PMLiVE

    Is your influenza clinical trial prepared for the upcoming flu season? Part 2

    Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell,...

    Innovative Trials

    - PMLiVE

    Is your influenza clinical trial prepared for the upcoming flu season? Part 1

    The Northern Hemisphere flu season is fast approaching, bringing with it a multitude of challenges for respiratory clinical trials. The exact dates of the flu season in the Northern Hemisphere...

    Innovative Trials

    - PMLiVE

    GSK’s mRNA seasonal flu vaccine shows promise in younger and older adults

    The company said it will now progress the programme into late-stage clinical development

    - PMLiVE

    Pfizer and BioNTech share late-stage results for COVID-19/flu combination vaccine

    The combined vaccine approach could simplify immunisation practices and lead to higher uptake

    - PMLiVE

    Patient Recruitment & Retention Webinar for Influenza Studies

    Join the upcoming webinar which will discuss key patient recruitment & retention challenges and solutions for upcoming influenza studies.

    Innovative Trials

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links